pharma · Critical Limb Ischemia (CLI) · Sarcoma · DSGN
Lxo Ireland Designated
Lxo Ireland Designated Activity Company
Lxo Ireland Designated clinical programs — 17 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- CARLSBAD, CA, IE
- Programs
- 68
- Drugs
- 61
- Patents
- 201
Lxo Ireland Designated projects
17 ClinicalTrials.gov programs sponsored by Lxo Ireland Designated.
Lxo Ireland Designated has 17 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
ANDA219975 + ANDA220011
Lxo Ireland Designated Activity Company
Type 2 Diabetes
1 trial -
Abiraterone - Usual
Lxo Ireland Designated Activity Company
Prostate Cancer
1 trial -
Alectinib - Usual
Lxo Ireland Designated Activity Company
ALK-Positive Non-Small Cell Lung Cancer (NSCLC)
1 trial -
Amchafibrin
Lxo Ireland Designated Activity Company
Osteoarthritis, Knee
1 trial -
Cloxacilin
Lxo Ireland Designated Activity Company
Staphylococcus
1 trial -
Conventional medical treatment
Lxo Ireland Designated Activity Company
Coronary Atherosclerosis and Other Heart Disease
1 trial -
Discontinuation antipsychotic treatment
Lxo Ireland Designated Activity Company
Psychosis Nos/Other
1 trial -
ETOPOSIDE - Usual
Lxo Ireland Designated Activity Company
Small Cell Lung Cancer
1 trial -
Influenza vaccine
Lxo Ireland Designated Activity Company
Infection in Solid Organ Transplant Recipients
1 trial -
LV305
Lxo Ireland Designated Activity Company
Synovial Sarcoma
1 trial -
Levodopa
Lxo Ireland Designated Activity Company
Ischaemic Stroke
1 trial -
Paclitaxel-releasing PTA balloon catheter
Lxo Ireland Designated Activity Company
Arteriovenous Fistula Renal Dialysis Devices Obstruction
1 trial -
Platelet rich plasma
Lxo Ireland Designated Activity Company
Coxarthrosis
1 trial -
REX-001
Lxo Ireland Designated Activity Company
Peripheral Arterial Disease (PAD)
2 trials -
Raloxifene - Usual
Lxo Ireland Designated Activity Company
Breast Cancer
1 trial -
Rituximab
Lxo Ireland Designated Activity Company
Lupus Nephritis
1 trial -
Topotecan - usual
Lxo Ireland Designated Activity Company
SCLC
1 trial
Frequently asked questions
How many clinical projects does Lxo Ireland Designated have?
17 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.